Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cochrane

Showing results (51-60 of 233) with videos related to

Pageof 24
Sort By:
The Journal of Clinical Investigation|April 1, 1976
The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the moleculeS D Revak, C G Cochrane
Chest|July 29, 1999
Surfactant lavage treatment in a model of respiratory distress syndromeC G Cochrane, S D Revak
Chest|March 1, 1994
Protein-phospholipid interactions in pulmonary surfactant. The Parker B. Francis LectureshipC G Cochrane, S D Revak
Infection and Immunity|January 1, 1978
Role of complement in lethal bacterial lipopolysaccharide-induced hypotensive and coagulative changesR J Ulevitch, C G Cochrane
The Veterinary Record|November 29, 1980
Use of synthetic pyrethroidsR N Titchener, D G Cochrane
International Journal of Cancer|January 15, 1974
The cellular events associated with regression and progression of murine (Moloney) sarcomasS W Russell, C G Cochrane
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1972
Effect of plasma kallikrein on coagulation in vitroK D Wuepper, C G Cochrane
The Journal of Experimental Medicine|January 1, 1972
Plasma prekallikrein: isolation, characterization, and mechanism of activationK D Wuepper, C G Cochrane
Journal of the Reticuloendothelial Society|August 1, 1970
Cellular mediators of immunological tissue injuryP M Henson, C G Cochrane
The Journal of Experimental Medicine|September 1, 1974
Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins)D C Morrison, C G Cochrane
Pageof 24

Showing results (51-60 of 233) with videos related to

Sort By:
Pageof 24
The Journal of Clinical Investigation|April 1, 1976
The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the moleculeS D Revak, C G Cochrane
Chest|July 29, 1999
Surfactant lavage treatment in a model of respiratory distress syndromeC G Cochrane, S D Revak
Chest|March 1, 1994
Protein-phospholipid interactions in pulmonary surfactant. The Parker B. Francis LectureshipC G Cochrane, S D Revak
Infection and Immunity|January 1, 1978
Role of complement in lethal bacterial lipopolysaccharide-induced hypotensive and coagulative changesR J Ulevitch, C G Cochrane
The Veterinary Record|November 29, 1980
Use of synthetic pyrethroidsR N Titchener, D G Cochrane
International Journal of Cancer|January 15, 1974
The cellular events associated with regression and progression of murine (Moloney) sarcomasS W Russell, C G Cochrane
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1972
Effect of plasma kallikrein on coagulation in vitroK D Wuepper, C G Cochrane
The Journal of Experimental Medicine|January 1, 1972
Plasma prekallikrein: isolation, characterization, and mechanism of activationK D Wuepper, C G Cochrane
Journal of the Reticuloendothelial Society|August 1, 1970
Cellular mediators of immunological tissue injuryP M Henson, C G Cochrane
The Journal of Experimental Medicine|September 1, 1974
Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins)D C Morrison, C G Cochrane
Pageof 24